Frontlight ResearchEarly access
Long COVID and ME/CFS trials in Zambia
1 trial · From ClinicalTrials.gov, checked 16 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in ZambiaLong Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study
- Where
- Lusaka
- Age
- 18 years to 65 years
- People
- 348 worldwide
- Run by
- Douglas D. Fraser
See details and how to joinNCT06928272